Table 3 Prognostic factors by Cox regression analysis

From: Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer

Clinicopathologic factors

Hazard ratio

95% confidence interval

P -value

Age (continuous variable)

0.979

0.609–1.575

0.9312

PSA level at biopsy (continuous variable)

0.999

0.997–1.000

0.526

Gleason score >7

1.635

1.000–2.671

0.0498

DRE positive

0.814

0.385–1.721

0.5907

Extraprostatic extension (+)

2.616

1.389–4.925

0.0029

Lymph node metastasis (+)

0.978

0.200–4.778

0.9778

Mast cell count >16

2.726

1.476–5.034

0.0014

  1. DRE=digital rectal examination; PSA=prostate-specific antigen.
Back to article page